Axogen, Inc. (LON:0HKD)
32.67
+0.98 (3.09%)
Feb 12, 2026, 5:07 PM GMT
Axogen Market Cap
Axogen has a market cap or net worth of 1.2 billion as of February 12, 2026. Its market cap has increased by 84.18% in one year.
Market Cap
1.20B
Enterprise Value
1.22B
Revenue
159.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
32.67
Market Cap Chart
Since October 3, 2011, Axogen's market cap has increased from 7.54M to 1.20B, an increase of 15,804.69%. That is a compound annual growth rate of 42.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.25B | 11.03% |
| Dec 31, 2025 | 1.12B | 93.61% |
| Dec 31, 2024 | 579.31M | 151.00% |
| Dec 29, 2023 | 230.80M | -34.10% |
| Dec 30, 2022 | 350.26M | 21.78% |
| Dec 31, 2021 | 287.61M | -45.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| Genus | 2.06B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.31B |
| Oxford Biomedica | 986.00M |